Euclidean Capital LLC
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), Euclidean Capital LLC reported 10 stock positions worth $736.7 million. Its top holding was SS SPDR S&P 500 ETF Trust-US (SPY) at 71.3% of the portfolio, followed by iShares MSCI India ETF (INDA, 17.3%) and Vanguard Ftse All-World Ex-U (VEU, 7.9%). Compared with Q3 2024, it sold out of 1, added to 1 and reduced 1. The biggest buy was Vanguard Ftse All-World Ex-U (VEU, shares +100%) and the biggest sale SS SPDR S&P 500 ETF Trust-US (SPY, shares −25%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001825034
- Portfolio Value
- $736.7M (Q4 2024)
- SEC Filing
- 0001012975-25-000088 ↗ filed Feb 14, 2025
Holdings Value
Holdings 10 stocks · $736.7M
| SPY SS SPDR S&P 500 ETF Trust-US | 71.30% | 896,254 | $525.3M | Reduce -25.5% |
| INDA iShares MSCI India ETF | 17.33% | 2,425,144 | $127.7M | No change |
| VEU Vanguard Ftse All-World Ex-U | 7.90% | 1,013,434 | $58.2M | Add +99.7% |
| ORIC Oric Pharmaceuticals Inc. | 1.08% | 989,410 | $8.0M | No change |
| FHTX Foghorn Therapeutics Inc. | 1.01% | 1,573,761 | $7.4M | No change |
| PMVP PMV Pharmaceuticals Inc. | 0.54% | 2,627,643 | $4.0M | No change |
| ALEC Alector Inc. | 0.34% | 1,307,858 | $2.5M | No change |
| TNYA Tenaya Therapeutics Inc. | 0.20% | 1,015,705 | $1.5M | No change |
| SRZN Surrozen Inc. | 0.17% | 87,696 | $1.3M | No change |
| RAPT THERAPEUTICS INC | 0.14% | 657,899 | $1.0M | No change |
Other holdings (1): bonds, preferreds, convertibles and warrants · $4K (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| SRZNW Surrozen Inc.-CW25 | *W EXP 08/01/203 | 170,833 | $4K | No change |
Total filed on the 13F, all lines: $736.7M.
Portfolio Sells Q3 2024 → Q4 2024
| SPY SS SPDR S&P 500 ETF Trust-US | Reduce -25.5% | 71.30% | −4.81 |
| 23ANDME HOLDING CO | Sold out | 0.00% | −0.40 |
Portfolio Buys Q3 2024 → Q4 2024
| VEU Vanguard Ftse All-World Ex-U | Add +99.7% | 7.90% | +4.37 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 10 | $439.8M | VEU, VTV, INDA, ORIC, TMS |
| Q1 2026 | 9 | $392.3M | VEU, VTV, INDA, ORIC, FHTX |
| Q4 2025 | 11 | $369.4M | VEU, VTV, INDA, FHTX, ORIC |
| Q3 2025 | 10 | $238.0M | VEU, INDA, ORIC, FHTX, ALEC |
| Q2 2025 | 10 | $305.7M | VEU, INDA, ORIC, FHTX, PMVP |
| Q1 2025 | 10 | $266.1M | INDA, VEU, FHTX, ORIC, PMVP |
| Q4 2024 | 10 | $736.7M | SPY, INDA, VEU, ORIC, FHTX |
| Q3 2024 | 11 | $906.8M | SPY, INDA, VEU, FHTX, ORIC |
| Q2 2024 | 10 | $795.8M | SPY, INDA, FHTX, ORIC, ALEC |
| Q1 2024 | 12 | $780.0M | SPY, INDA, GLD, ORIC, FHTX |